2009 Focused Updates: STEMI and PCI Guidelines
暂无分享,去创建一个
J. Ornato | E. Antman | Jeffrey L. Anderson | H. Krumholz | A. Jacobs | L. Green | E. Peterson | S. Bailey | David O. Williams | J. Hochman | S. King | J. Blankenship | E. Bates | M. Sloan | P. Whitlow | F. Kushner | D. Pearle | A. Jacobs | D. L. Pearle
[1] B. Gersh,et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. , 2009, The New England journal of medicine.
[2] J. Ferrières,et al. Genetic determinants of response to clopidogrel and cardiovascular events. , 2009, The New England journal of medicine.
[3] U. Siebert,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.
[4] L. Morrison,et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. , 2009, The New England journal of medicine.
[5] Antonio Colombo,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.
[6] R. Califf,et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. , 2009, The New England journal of medicine.
[7] S. Yusuf,et al. Early versus delayed invasive intervention in acute coronary syndromes. , 2009, The New England journal of medicine.
[8] E. Antman,et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials , 2009, The Lancet.
[9] A. Kaltoft,et al. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. , 2009, European heart journal.
[10] E. Antman,et al. Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON‐TIMI 38 , 2009, Journal of clinical pharmacology.
[11] V. Bezlyak,et al. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial , 2009, The Lancet.
[12] H. Gurm,et al. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. , 2009, JACC. Cardiovascular interventions.
[13] E. Antman,et al. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial. , 2009, European heart journal.
[14] Richard Hellman,et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[15] Harlan M Krumholz,et al. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study , 2009, BMJ : British Medical Journal.
[16] G. De Luca,et al. Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. , 2009, Journal of the American College of Cardiology.
[17] P. Teirstein,et al. Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial. , 2009, American heart journal.
[18] C. Albert,et al. Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women , 2009, Circulation.
[19] G. Paolisso,et al. Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. , 2009, Journal of the American College of Cardiology.
[20] H. Gurm,et al. A Comparison of Abciximab and Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis of Contemporary Randomized Controlled Trials , 2009, Circulation. Cardiovascular interventions.
[21] H. Krumholz,et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. , 2009, JAMA.
[22] S. Nekolla,et al. Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial , 2009, Circulation.
[23] G. Stone,et al. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. , 2009, International journal of cardiology.
[24] E. Antman,et al. Cytochrome p-450 polymorphisms and response to clopidogrel. , 2009, The New England journal of medicine.
[25] P. Gurbel,et al. The drug–drug interaction between proton pump inhibitors and clopidogrel , 2009, Canadian Medical Association Journal.
[26] Peter C. Austin,et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel , 2009, Canadian Medical Association Journal.
[27] Stephane Heritier,et al. Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.
[28] B. Giusti,et al. Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis. , 2009, The American journal of cardiology.
[29] M. Hadamitzky,et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel , 2009, Thrombosis and Haemostasis.
[30] P. Armstrong,et al. Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction. , 2009, Circulation.
[31] P Michael Ho,et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. , 2009, JAMA.
[32] E. Antman,et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial , 2009, The Lancet.
[33] E. W. Hancock,et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Card , 2009, Circulation.
[34] F. Fedele,et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. , 2009, Journal of the American College of Cardiology.
[35] G. Montalescot,et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study , 2009, The Lancet.
[36] A. Kastrati,et al. Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention. , 2008, European heart journal.
[37] W. Bautz,et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. , 2009, Radiology.
[38] E. DeLong,et al. ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. , 2008, Circulation.
[39] J. Dery,et al. Nonrandomized Comparison of Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention for the Treatment of Unprotected Left Main Coronary Artery Disease in Octogenarians , 2008, Circulation.
[40] Deepak L. Bhatt,et al. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. , 2008, European heart journal.
[41] S. Normand,et al. Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus: Results From the Massachusetts Data Analysis Center Registry , 2008, Circulation.
[42] D. Mark,et al. Clopidogrel use and bleeding after coronary artery bypass graft surgery. , 2008, American heart journal.
[43] S. Steinhubl,et al. Abstract 3999: Baseline Proton Pump Inhibitor Use is Associated with Increased Cardiovascular Events With and Without the Use of Clopidogrel in the CREDO Trial , 2008 .
[44] R. Epstein,et al. Abstract 3998: Proton Pump Inhibitors Effect on Clopidogrel Effectiveness: The Clopidogrel Medco Outcomes Study , 2008 .
[45] E. Antman. Time is muscle: translation into practice. , 2008, Journal of the American College of Cardiology.
[46] Deepak L. Bhatt,et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. , 2008, Circulation.
[47] W. Laskey,et al. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. , 2008, American heart journal.
[48] S. Normand,et al. Drug-eluting or bare-metal stents for acute myocardial infarction. , 2008, The New England journal of medicine.
[49] Renda Soylemez Wiener,et al. Ill Adults: A Meta-analysis Benefits and Risks of Tight Glucose Control in Critically , 2010 .
[50] J. Ottervanger,et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial , 2008, The Lancet.
[51] Deepak L. Bhatt,et al. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. , 2008, American heart journal.
[52] E. V. van Beek,et al. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. , 2008, AJR. American journal of roentgenology.
[53] P. Raskin,et al. Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2008, Anesthesiology.
[54] F. Zijlstra,et al. Thrombus aspiration during primary percutaneous coronary intervention. , 2008, The New England journal of medicine.
[55] F. Zijlstra,et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study , 2008, The Lancet.
[56] P. Shah,et al. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. , 2008, JACC. Cardiovascular interventions.
[57] E. Topol,et al. Facilitated PCI in patients with ST-elevation myocardial infarction. , 2008, The New England journal of medicine.
[58] B. Gersh,et al. Bivalirudin during primary PCI in acute myocardial infarction. , 2008, The New England journal of medicine.
[59] Young-Hak Kim,et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. , 2008, The New England journal of medicine.
[60] F. Prati,et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. , 2008, JAMA.
[61] S. Stevens,et al. Rescue angioplasty for failed thrombolysis in older patients: insights from the REACT trial. , 2008, International journal of cardiology.
[62] P. Barragan,et al. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study. , 2008, Journal of the American College of Cardiology.
[63] K. Winters,et al. Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel , 2008, Journal of clinical pharmacology.
[64] Samin K. Sharma,et al. Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction. , 2008, JACC. Cardiovascular interventions.
[65] G. Stone,et al. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. , 2008, The American journal of cardiology.
[66] J. Brinker. The left main facts: faced, spun, but alas too few. , 2008, Journal of the American College of Cardiology.
[67] S. Yusuf,et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. , 2008, Journal of the American College of Cardiology.
[68] H. Thomsen,et al. The ACTIVE Trial: Comparison of the Effects on Renal Function of Iomeprol-400 and Iodixanol-320 in Patients With Chronic Kidney Disease Undergoing Abdominal Computed Tomography , 2008, Investigative radiology.
[69] M. Flather,et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial , 2008, The Lancet.
[70] D. Dudek,et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. , 2008, Journal of the American College of Cardiology.
[71] C. Sosnowski. [Commentary to the article: Wiviott S D, Braunwald E, McCabe C H et al. Prasugrel versus clopidogrel in patients with acute coronary syndrome. N Engl J Med 2007; 357: 2001-15]. , 2008, Kardiologia polska.
[72] R. Wilensky,et al. A comparison of bare-metal and drug-eluting stents for off-label indications. , 2008, The New England journal of medicine.
[73] Dominique Mottier,et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. , 2008, Journal of the American College of Cardiology.
[74] J. Trickett,et al. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. , 2008, The New England journal of medicine.
[75] Jeffrey L. Anderson,et al. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[76] Christopher E. Buller,et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2008, Circulation.
[77] S. Ellis,et al. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. , 2008, The American journal of cardiology.
[78] J. Dery,et al. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[79] William Wijns,et al. [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[80] E. Antman,et al. Prasugrel Compared With High Loading– and Maintenance–Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial , 2007, Circulation.
[81] Marco Valgimigli,et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. , 2007, European heart journal.
[82] A. Íñiguez,et al. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. , 2007, The American journal of cardiology.
[83] A. Jacobs,et al. Regional systems of care for patients with ST-elevation myocardial infarction: being at the right place at the right time. , 2007, Circulation.
[84] B. Gersh,et al. Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for ST-Elevation Myocardial Infarction: The Mayo Clinic STEMI Protocol , 2007, Circulation.
[85] Timothy D. Henry,et al. A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction , 2007, Circulation.
[86] E. Antman,et al. Development of Systems of Care for ST-Elevation Myocardial Infarction Patients , 2007 .
[87] P. Serruys,et al. Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery: A Multicenter Registry , 2007, Circulation.
[88] Samin K. Sharma,et al. Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.
[89] Deepak L. Bhatt,et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. , 2007, Journal of the American College of Cardiology.
[90] V. Pasceri,et al. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. , 2007, American heart journal.
[91] J. Ioannidis,et al. Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. , 2007, The American journal of cardiology.
[92] J. Ware,et al. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. , 2007, JAMA.
[93] C. Grines,et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D , 2007, Journal of the American College of Cardiology.
[94] J. E. Sousa,et al. Anatomical and physiologic assessments in patients with small coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial. , 2007, American heart journal.
[95] J. Tu,et al. Clinical ResearchInterventional CardiologyRescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta-Analysis of Randomized Trials , 2007 .
[96] R. Shaw,et al. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug‐eluting stent era—a report from the American College of Cardiology‐National Cardiovascular data registry (ACC‐NCDR) , 2006 .
[97] David P Miller,et al. Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy , 2006, Circulation.
[98] G. Montalescot,et al. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. , 2006, Journal of the American College of Cardiology.
[99] E. Antman,et al. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). , 2006, American heart journal.
[100] F. Werf,et al. Drug-eluting stents in acute myocardial infarction. , 2006, The New England journal of medicine.
[101] Young‐Bae Park,et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.
[102] J. Brinker,et al. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.
[103] A. Branzi,et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). , 2006, The American journal of cardiology.
[104] D. Faxon,et al. Left main coronary revascularization at the crossroads. , 2006, Circulation.
[105] O. Alfieri,et al. Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience , 2006, Circulation.
[106] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[107] S. Ghiringhelli,et al. Performing versus deferring coronary angioplasty based on functional evaluation of vessel stenosis by pressure measurements: a clinical outcome study , 2006, Journal of cardiovascular medicine.
[108] D. Baim,et al. Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery? , 2006, Journal of the American College of Cardiology.
[109] P. Shah,et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. , 2006, Journal of the American College of Cardiology.
[110] Harlan M Krumholz,et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El , 2006, Journal of the American College of Cardiology.
[111] Joseph P Ornato,et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[112] S. Stevens,et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. , 2005, The New England journal of medicine.
[113] William Wijns,et al. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. , 2005, Journal of the American College of Cardiology.
[114] F. Neumann,et al. Time Dependence of Platelet Inhibition After a 600-mg Loading Dose of Clopidogrel in a Large, Unselected Cohort of Candidates for Percutaneous Coronary Intervention , 2005, Circulation.
[115] A. Skene,et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. , 2005, The New England journal of medicine.
[116] I. Iakovou,et al. Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main , 2005, Circulation.
[117] A. Michelson. Platelet function testing in cardiovascular diseases. , 2004, Circulation.
[118] K. Takazawa,et al. Application of Pressure-Derived Myocardial Fractional Flow Reserve in Assessing the Functional Severity of Coronary Artery Stenosis in Patients With Diabetes Mellitus , 2004 .
[119] O. Penn,et al. Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[120] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[121] H. Diener,et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.
[122] E. Topol,et al. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. , 2004, American heart journal.
[123] T. Harr,et al. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials. , 2004, The American journal of medicine.
[124] G. Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.
[125] A. Kastrati,et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. , 2003, JAMA.
[126] Deepak L. Bhatt,et al. Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. , 2003, Archives of internal medicine.
[127] Sankey V. Williams,et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.
[128] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .
[129] K. Takazawa,et al. Correlation between thallium-201 myocardial perfusion defects and the functional severity of coronary artery stenosis as assessed by pressure-derived myocardial fractional flow reserve. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[130] Eric J Topol,et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.
[131] R. Califf,et al. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. , 2002, JAMA.
[132] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[133] C. Di Mario,et al. Results and Long-Term Predictors of Adverse Clinical Events After Elective Percutaneous Interventions on Unprotected Left Main Coronary Artery , 2002, Circulation.
[134] J. Tijssen,et al. Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. , 2002, The American journal of cardiology.
[135] R. Califf,et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.
[136] Seung‐Jung Park,et al. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. , 2001, Journal of the American College of Cardiology.
[137] Salim Yusuf,et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study , 2001, The Lancet.
[138] L. Clark,et al. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials. , 2001, The American journal of cardiology.
[139] S. Yusuf,et al. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. , 2000, European heart journal.
[140] A. Oktay,et al. Correlation of myocardial fractional flow reserve with thallium-201 SPECT imaging in intermediate-severity coronary artery lesions. , 1999, The Journal of invasive cardiology.
[141] H Wedel,et al. Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .
[142] P. H. van der Voort,et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.